Progressnotes - October/November 2012
- About MUSC Health
Andrew S. Kraft, M.D., is Director of the Hollings Cancer Center (HCC) at the Medical University of South Carolina (MUSC). Dr. Kraft is a Professor of Medicine and Biochemistry and Molecular Biology as well as Associate Dean of Oncologic Affairs at MUSC. He holds the distinguished William H. Folk, M.D., Chair in Experimental Oncology.
Dr. Kraft’s research focus is prostate cancer, sarcomas, and novel cancer drug development. He has been continuously funded since 1990 by the National Cancer Institute (NCI), the Department of Defense, and the Prostate Cancer Research Foundation. Under Dr. Kraft’s leadership, the HCC was named an NCI-designated cancer center in 2009, a distinction shared by only 66 other cancer centers in the United States.
Dr. Kraft is a member of numerous professional societies, including the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Cancer Research, and the American Society of Hematology. He has more than 100 peer-reviewed publications in leading journals such as the Journal of Biologic Chemistry, Molecular Cell Biology, Blood, and Oncogene.
Dr. Kraft received his Bachelors of Science degree from Bucknell University in 1971 and his medical degree from the University of Pennsylvania School of Medicine in 1975. He completed his residency at the Mount Sinai Hospital in New York, New York. Dr. Kraft spent the next five years at the NCI in Bethesda, Maryland training in the Laboratory of Pathophysiology and completing his clinical fellowship in hematology/oncology.